Pro-life CEO predicts Trump FDA nominee could bring renewed scrutiny to abortion drug risks

Trump's FDA nominee Heidi Overton could bring renewed scrutiny to mifepristone, says Americans United for Life CEO who calls her a "pro-life" pick.